R&D Partner Content Revolutionising Clinical Trials: Evolution Summit 2025 Retur... Marcus Evans is proud to announce the Evolution Summit September 2025, an exclusive, invitation-only event bringing together leading clinical trial executives, innovative suppliers
R&D Partner Content Welcome to the 3rd Spatial Biology for Drug Development Summ... Transforming Research & Development with Faster, More Precise Spatial Insights
Partner Content Partner Content 2nd Hit ID Summit Why prioritise your hit discovery game? Finding the right chemical start points is crucial to help you save time and costs in the long run.
R&D Partner Content Unlocking the Potential of Targeting the Innate Immune Syste... Ready to Catalyze the Next Wave of Inflammasome Therapies?
Partner Content Partner Content 5th Oligonucleotides for CNS Summit The Oligonucleotides for CNS Summit returns for its 5th year to address key challenges in durability, scalability, potency and CNS tropism
R&D Partner Content 2nd ADC & Novel Conjugates Partnering & Investment Summit Refine your strategy, sharpen your positioning, and meet the right partners - all at the most efficient networking event of the ADCconference calendar
News Argenx pens $2.2bn deal to buy autoimmune biotech Forte Netherlands- and Belgium-based argenx has agreed to buy US biotech Forte Bio for up to $2.2bn, bolstering its autoimmune disease pipeline.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.